Literature DB >> 11282253

Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents.

R Yirmiya1, Y Pollak, O Barak, R Avitsur, H Ovadia, M Bette, E Weihe, J Weidenfeld.   

Abstract

Antidepressants produce various immunomodulatory effects, as well as an attenuation of the behavioral responses to immune challenges, such as lipopolysaccharide (LPS). To explore further the effects of antidepressants on neuroimmune interactions, rats were treated daily with either fluoxetine (Prozac) or saline for 5 weeks, and various behavioral, neuroendocrine, and immune functions were measured following administration of either LPS or saline. Chronic fluoxetine treatment significantly attenuated the anorexia and body weight loss, as well as the depletion of CRH-41 from the median eminence and the elevation in serum corticosterone levels induced by LPS. Chronic treatment with imipramine also attenuated LPS-induced adrenocortical activation. In rats and in mice, which normally display a biphasic body temperature response to LPS (initial hypothermia followed by hyperthermia), chronic treatment with fluoxetine completely abolished the hypothermic response and facilitated and strengthened the hyperthermic response. The effects of antidepressants on the responsiveness to LPS are probably not mediated by their effects on peripheral proinflammatory cytokine production, because LPS-induced expression of TNFalpha and IL-1beta mRNA in the spleen (assessed by semiquantitative in situ hybridization) was not altered following chronic treatment with either fluoxetine or imipramine. The effects of antidepressants on the acute phase response may have important clinical implications for the psychiatric and neuroendocrine disturbances that are commonly associated with various medical conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282253     DOI: 10.1016/S0893-133X(00)00226-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  52 in total

1.  Serotonin as a putative scavenger of hypohalous acid in the brain.

Authors:  Mike Kalogiannis; E James Delikatny; Thomas M Jeitner
Journal:  Biochim Biophys Acta       Date:  2015-12-14

Review 2.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

3.  P2X(7) Receptors in Neurological and Cardiovascular Disorders.

Authors:  Stephen D Skaper; Patrizia Debetto; Pietro Giusti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-06-24

Review 4.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

5.  Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior.

Authors:  A C Kentner; S A McLeod; E F Field; Q J Pittman
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

Review 6.  Microglia: A Central Player in Depression.

Authors:  Si-Long Deng; Jian-Guo Chen; Fang Wang
Journal:  Curr Med Sci       Date:  2020-07-17

Review 7.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Microglia Loss Contributes to the Development of Major Depression Induced by Different Types of Chronic Stresses.

Authors:  Lijuan Tong; Yu Gong; Peng Wang; Wenfeng Hu; Jili Wang; Zhuo Chen; Wei Zhang; Chao Huang
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

Review 9.  Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.

Authors:  Ja Wook Koo; Ronald S Duman
Journal:  Curr Opin Investig Drugs       Date:  2009-07

Review 10.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.